Special focus is placed on novel insights into the signal transduction pathways affected by the disease and genotype phenotype correlations. Existing and potential therapies are also discussed in depth.
The editors are leading experts in research and treatment of the disease. Dr. Vicky Holets Whittemore is, for example, the Vice President of the Tuberous Sclerosis Alliance, the only voluntary health organization for TSC in the USA.
- The only comprehensive title on the genetic disorder Tuberous Sclerosis on the market.
- Gives up to date information about the molecular basis, diagnosis and therapies.
- Edited and authored by researchers and clinicians with outstanding international reputation as well as prominent figures in the largest patient advocacy group.
- Indispensable for doctors, researchers and patients.